Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.03 +0.02 (+2.46%)
As of: Oct 21, 2026 · 2:15 PM EDT

Telomir Pharmaceuticals (TELO) Net Income (2023 - 2026)

Updated

Analysis

Telomir Pharmaceuticals (TELO) Net Income (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn 5.53 Bn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn 3.62 Bn
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 2.51 Bn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn -10.50 Bn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn -248.00 Mn
10 Telomir Pharmaceuticals 62.97 Mn 42.40 Mn - -1.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.72 Mn
Dec 31, 2025 -2.01 Mn
Sep 30, 2025 -1.10 Mn
Jun 30, 2025 -5.07 Mn
Mar 31, 2025 -2.18 Mn
Dec 31, 2024 -2.90 Mn
Sep 30, 2024 -5.99 Mn
Jun 30, 2024 -1.39 Mn
Mar 31, 2024 -6.25 Mn
Dec 31, 2023 -9.33 Mn
Sep 30, 2023 -1.71 Mn
Jun 30, 2023 -1.55 Mn
Mar 31, 2023 -482,938.00
API Access

Telomir Pharmaceuticals Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=TELO&period=max&api_key=YOUR_API_KEY